Cargando…

Enhanced Muscle Strength in Dyslipidemic Mice and Its Relation to Increased Capacity for Fatty Acid Oxidation

Dyslipidemia is commonly linked to skeletal muscle dysfunction, accumulation of intramyocellular lipids, and insulin resistance. However, our previous research indicated that dyslipidemia in apolipoprotein E and low-density lipoprotein receptor double knock-out mice (ApoE/LDLR -/-) leads to improvem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomczyk, Marta, Braczko, Alicja, Jablonska, Patrycja, Mika, Adriana, Przyborowski, Kamil, Jedrzejewska, Agata, Krol, Oliwia, Kus, Filip, Sledzinski, Tomasz, Chlopicki, Stefan, Slominska, Ewa M., Smolenski, Ryszard T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620496/ https://www.ncbi.nlm.nih.gov/pubmed/34830135 http://dx.doi.org/10.3390/ijms222212251

Ejemplares similares

Cardiac Mitochondria Dysfunction in Dyslipidemic Mice
por: Braczko, Alicja, et al.
Publicado: (2022)

Rosiglitazone Ameliorates Cardiac and Skeletal Muscle Dysfunction by Correction of Energetics in Huntington’s Disease
por: Tomczyk, Marta, et al.
Publicado: (2022)

Macrophage-Derived Adenosine Deaminase 2 Correlates with M2 Macrophage Phenotype in Triple Negative Breast Cancer
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2021)

Differences in Extracellular NAD(+) and NMN Metabolism on the Surface of Vascular Endothelial Cells
por: Jablonska, Patrycja, et al.
Publicado: (2022)

Serum fatty acid profiles in breast cancer patients following treatment
por: Pakiet, Alicja, et al.
Publicado: (2023)

Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
por: Jedrzejewska, Agata, et al.
Publicado: (2022)

Hidden Pool of Cardiac Adenine Nucleotides That Controls Adenosine Production
por: Zabielska-Kaczorowska, Magdalena A., et al.
Publicado: (2023)

An unusual nicotinamide derivative, 4-pyridone-3-carboxamide ribonucleoside (4PYR), is a novel endothelial toxin and oncometabolite
por: Mierzejewska, Paulina, et al.
Publicado: (2021)

CoCl(2)-Mimicked Endothelial Cell Hypoxia Induces Nucleotide Depletion and Functional Impairment That Is Reversed by Nucleotide Precursors
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2022)

The new insight into extracellular NAD(+) degradation‐the contribution of CD38 and CD73 in calcific aortic valve disease
por: Jablonska, Patrycja, et al.
Publicado: (2021)

One Anastomosis Gastric Bypass Reconstitutes the Appropriate Profile of Serum Amino Acids in Patients with Morbid Obesity
por: Halinski, Lukasz P., et al.
Publicado: (2019)

High Throughput Procedure for Comparative Analysis of In Vivo Cardiac Glucose or Amino Acids Use in Cardiovascular Pathologies and Pharmacological Treatments
por: Tomczyk, Marta, et al.
Publicado: (2021)

Inorganic Polyphosphate—Regulator of Cellular Metabolism in Homeostasis and Disease
por: Kus, Filip, et al.
Publicado: (2022)

Purine Nucleotides Metabolism and Signaling in Huntington’s Disease: Search for a Target for Novel Therapies
por: Tomczyk, Marta, et al.
Publicado: (2021)

Antiplatelet Effect of Carbon Monoxide Is Mediated by NAD(+) and ATP Depletion
por: Kaczara, Patrycja, et al.
Publicado: (2020)

Distinct Pharmacological Properties of Gaseous CO and CO-Releasing Molecule in Human Platelets
por: Kaczara, Patrycja, et al.
Publicado: (2021)

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR)—A Novel Oncometabolite Modulating Cancer-Endothelial Interactions in Breast Cancer Metastasis
por: Koszalka, Patrycja, et al.
Publicado: (2022)

Nucleotide ecto-enzyme metabolic pattern and spatial distribution in calcific aortic valve disease; its relation to pathological changes and clinical presentation
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2019)

Systemic Effects of Radiotherapy and Concurrent Chemo-Radiotherapy in Head and Neck Cancer Patients—Comparison of Serum Metabolome Profiles
por: Jelonek, Karol, et al.
Publicado: (2020)

Metabolic Effects of New Glucose Transporter (GLUT-1) and Lactate Dehydrogenase-A (LDH-A) Inhibitors against Chemoresistant Malignant Mesothelioma
por: Franczak, Marika A., et al.
Publicado: (2023)

Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019
por: Jedrzejewska, Agata, et al.
Publicado: (2023)

Influence of Electronic Cigarettes on Antioxidant Capacity and Nucleotide Metabolites in Saliva
por: Cichońska, Dominika, et al.
Publicado: (2021)

Therapeutic Perspectives of Adenosine Deaminase Inhibition in Cardiovascular Diseases
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2020)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

P050: Reed-Sternberg cells accelerate glycolytic and mitochondrial metabolism of tumor microenvironment cells
por: Kurlapski, Michał, et al.
Publicado: (2022)

Adenosine deaminase inhibition suppresses progression of 4T1 murine breast cancer by adenosine receptor‐dependent mechanisms
por: Kutryb‐Zajac, Barbara, et al.
Publicado: (2018)

Protein disulfide isomerase‐A1 regulates intraplatelet reactive oxygen species–thromboxane A(2)‐dependent pathway in human platelets
por: Przyborowski, Kamil, et al.
Publicado: (2021)

Functional and Biochemical Endothelial Profiling In Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-converting Enzyme Inhibitor
por: Bar, Anna, et al.
Publicado: (2017)

The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid
por: Kutryb-Zajac, Barbara, et al.
Publicado: (2022)

Blocking cholesterol formation and turnover improves cellular and mitochondria function in murine heart microvascular endothelial cells and cardiomyocytes
por: Braczko, Alicja, et al.
Publicado: (2023)

Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy
por: Maszka, Patrycja, et al.
Publicado: (2023)

Dyslipidemic drugs in metabolic syndrome
por: Siddiqi, Sheelu S., et al.
Publicado: (2013)

Effects of 1-Methylnicotinamide (MNA) on Exercise Capacity and Endothelial Response in Diabetic Mice
por: Przyborowski, Kamil, et al.
Publicado: (2015)

Exercise capacity and cardiac hemodynamic response in female ApoE/LDLR(−/−) mice: a paradox of preserved V’O(2max) and exercise capacity despite coronary atherosclerosis
por: Wojewoda, M., et al.
Publicado: (2016)

4-Pyridone-3-carboxamide-1-β-D-ribonucleoside Triphosphate (4PyTP), a Novel NAD(+) Metabolite Accumulating in Erythrocytes of Uremic Children: A Biomarker for a Toxic NAD(+) Analogue in Other Tissues?
por: Synesiou, Elena, et al.
Publicado: (2011)

Beneficial Effects of RNS60 in Cardiac Ischemic Injury
por: Zabielska-Kaczorowska, Magdalena A., et al.
Publicado: (2022)

1-Methylnicotinamide and nicotinamide: two related anti-inflammatory agents that differentially affect the functions of activated macrophages
por: Biedroń, Rafał, et al.
Publicado: (2008)

Impaired l-arginine metabolism marks endothelial dysfunction in CD73-deficient mice
por: Mierzejewska, P., et al.
Publicado: (2019)

Pharmacokinetic interaction of garlic and atorvastatin in dyslipidemic rats
por: Reddy, G. Dilip, et al.
Publicado: (2012)

Serum lysophospholipid levels are altered in dyslipidemic hamsters
por: Suárez-García, Susana, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jtugk72aod3p9d47e0698a9vf3